Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose escalation and randomized withdrawal study of GSK189254 in narcolepsy
2006-002088-18Phase 2Terminated
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in narcolepsy comparing GSK189254 continuation arm with Placebo withdrawal arm (2 arms). Primary endpoint: Sleep latency on Maintenance of Wakefulness Test. Started Jul 2006; status: terminated.
02
Drugs
GSK189254
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2006-002088-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002088-18.